$NFLX Recent News What FCC decision means for cable-cord

New Post Public Reply Private Reply Replies (0) Message Board

Jan 17, 2014 at 4:05 PM

$NFLX Recent News

What FCC decision means for cable-cord cutters 1:07 p.m. Today - Quentin Fottrell
The 8 trends that will make or break you in 2014 12:31 p.m. Today - J.J. Zhang
S&P 500 ekes out record close; GM, Netflix sink: Stock market live blog recap 4:17 p.m. Jan. 15, 2014 - blogs.marketwatch.com
Dr. Doom, aka your dad, says Facebook's a 'fad' 10:24 a.m. Jan. 15, 2014 - blogs.marketwatch.com
10 things not to buy in 2014 8:03 a.m. Jan. 12, 2014 - AnnaMaria Andriotis
Tech stocks come to life late, close with gains 4:22 p.m. Jan. 10, 2014 - Rex Crum
Tech stocks edge upward with mild gains 9:57 a.m. Jan. 10, 2014 - Rex Crum
Tech stocks rise despite Apple and Twitter losses 5:01 p.m. Jan. 7, 2014 - Rex Crum
J.P. Morgan shares hit by $1.7 bln Madoff settlement 4:41 p.m. Jan. 7, 2014 - Saumya Vaishampayan
Pressure’s on Netflix in second ‘House Of Cards’ season 4:38 p.m. Jan. 7, 2014 - Rex Crum
Stocks rally as S&P 500 scores first gain in 2014 4:30 p.m. Jan. 7, 2014 - Victor Reklaitis
Stock market live blog (recap): U.S. stocks rally; S&P 500 snaps losing streak 3:45 p.m. Jan. 7, 2014 - blogs.marketwatch.com
Newscast: Stocks go for first win of 2014 2:25 p.m. Jan. 7, 2014 - MarketWatch
Tech stocks mostly rise in early trading 9:48 a.m. Jan. 7, 2014 - Rex Crum
Netflix shares drop after Morgan Stanley downgrade 8:28 a.m. Jan. 7, 2014 - Saumya Vaishampayan
Netflix shares down 3.6% after downgrade 8:21 a.m. Jan. 7, 2014 - Saumya Vaishampayan
Netflix cut to underweight: Morgan Stanley 8:20 a.m. Jan. 7, 2014 - Saumya Vaishampayan
Pandora gains; Twitter, Microsoft pace tech losses 4:58 p.m. Jan. 6, 2014 - Rex Crum
Icahn, Ireland set to access bond market this week 2:55 p.m. Jan. 6, 2014 - blogs.marketwatch.com
What investors can get out of CES 7:30 p.m. Jan. 3, 2014 - Benjamin Pimentel

Netflix Could Crash -- Hard -- Next Week 2:29 p.m. Today - TheStreet.com
Gutless Wall Street Analysts Irresponsible on Best Buy 1:05 p.m. Today - TheStreet.com
Taking a Contrarian View on Blackberry 12:00 p.m. Today - RealMoney.com
Recognize the Value of Booking Profits 11:00 a.m. Today - RealMoney.com
Is International Business Machines (IBM) Poised to Beat Earnings? - Analyst Blog 10:10 a.m. Today - Zacks.com
Analyst: Netflix Starting to Feel Pressure 9:44 a.m. Today - Wall St. Cheat Sheet
Stocks 2014: Investing for Growth - The Power and Protection of High Compounding Earnings ... 5:10 p.m. Jan. 16, 2014 - GuruFocus.com
Compuware Upgrades Strobe - Analyst Blog 4:20 p.m. Jan. 16, 2014 - Zacks.com
Netflix Shares Down on Pricing Woes - Analyst Blog 2:30 p.m. Jan. 16, 2014 - Zacks.com
Stocks 2014: Investing For Growth - The Power And Protection Of High Compounding Earnings Growth - Part 2 1:19 p.m. Jan. 16, 2014 - Seeking Alpha
Netflix Lags as Tesla Leads Momentum Race 10:21 a.m. Jan. 16, 2014 - TheStreet.com
Some Cracks in the Q4 Armor? - Ahead of Wall Street 10:11 a.m. Jan. 16, 2014 - Zacks.com
Sundance Starts: What to Expect at the Indie Festival 7:30 a.m. Jan. 16, 2014 - TheStreet.com
Net Neutrality Doesn't Matter 6:00 a.m. Jan. 16, 2014 - TheStreet.com
'Fast Money' Recap: Still in a Bull Market 5:00 a.m. Jan. 16, 2014 - TheStreet.com
Netflix Inc. (NFLX): Today's Featured Specialty Retail Laggard 5:01 p.m. Jan. 15, 2014 - TheStreet.com
Which Companies Will Take a Hit From the Death of Net Neutrality? 4:26 p.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Will Ruling Make Web Like Cable? 2:24 p.m. Jan. 15, 2014 - WSJ.com
Netflix to Stream Marco Polo - Analyst Blog 2:20 p.m. Jan. 15, 2014 - Zacks.com
Net Neutrality Ruling a Potential Nightmare for NFLX, Consumers 8:37 a.m. Jan. 15, 2014 - InvestorPlace.com

Netflix Original Series Based on the Epic Adventures of Marco Polo to Premiere in Late 2014 9:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Netflix To Bring Back Original Series "Lilyhammer" For Third Season 9:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Netflix to Announce Fourth-Quarter 2013 Financial Results 1:00 p.m. Jan. 8, 2014 - PR Newswire
Stock Technical Review: Las Vegas Sands, Sears Holdings, Netflix, and Dunkin' Brands Group 8:00 a.m. Jan. 3, 2014 - PR Newswire
New Year's Eve Events, Credit Facilities, and Stock Movements - Research Report on Netflix, Las Vegas Sands, Best Buy, Pandora, and SiriusXM 8:00 a.m. Dec. 31, 2013 - PR Newswire
Netflix Announces Termination of Stockholder Rights Plan 4:00 p.m. Dec. 30, 2013 - PR Newswire
Netflix Finds More Than Half of Americans Willing To Trade Their Couches For Treadmills When Binge Watching In 2014 7:00 a.m. Dec. 30, 2013 - PR Newswire
Morning Buzzers: Twitter Inc, Tiger Oil and Energy, Herbalife Ltd, Netflix, Inc 11:05 a.m. Dec. 27, 2013 - ACCESSWIRE
Critical Alerts For Goldman Sachs, Netflix, Goldcorp, Symantec, and KB Home Released By InvestorsObserver 9:31 a.m. Dec. 20, 2013 - PR Newswire
New Shows, Recognitions, and New Appointments - Research Report on Netflix, SiriusXM, CBS, Pandora, and Madison Square Garden 8:00 a.m. Dec. 20, 2013 - PR Newswire
Technological Innovations, Strategic Acquisitions, and Insider Trading Alert - Research Report on Exxon Mobil, Netflix, Chesapeake Energy, and Bank of America 8:55 a.m. Dec. 18, 2013 - PR Newswire
"Breaking Bad" Spin-off "Better Call Saul" Coming to Netflix Streaming Members Globally in 2014 9:00 a.m. Dec. 16, 2013 - PR Newswire
Quarterly Results, Cloud Player Integrations, New Series Launch, Executive Appointments, and Public Takeover Offers - Research Report on Ulta Beauty, Amazon, Netflix, eBay, and McKesson 8:00 a.m. Dec. 11, 2013 - PR Newswire
BoJack Is Back And Only On Netflix! 6:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Netflix Elects Greg Whiteley's Mitt To Join Original Documentary Slate 4:05 p.m. Dec. 9, 2013 - PR Newswire
Emmy-Award Winning Netflix Original Series, "House of Cards" Returns For Second Season Friday, February 14 10:30 a.m. Dec. 4, 2013 - PR Newswire
Exclusive Offerings, Expansions, Financial Results, Upcoming Conference calls, and Dividends - Research Report on Netflix, The Fresh Market, J.C. Penney, Best Buy, and Dollar General 8:00 a.m. Nov. 27, 2013 - PR Newswire
Stocks Showing Positive Trend: Federal National Mortgage Association, Netflix, Teva Pharmaceutical Industries, Sirius XM Radio, eBay Inc 8:44 a.m. Nov. 21, 2013 - PR Newswire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...